• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.34% Nasdaq Down 2.03%

    Mast Therapeutics, Inc. (MSTX)

    -NYSE MKT
    0.47 Down 0.01(2.62%) 1:17PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.49
    Open:0.48
    Bid:0.47 x 300
    Ask:0.48 x 5000
    1y Target Est:2.38
    Beta:0.870879
    Earnings Date:Oct 29 - Nov 2 (Est.)
    Day's Range:0.45 - 0.48
    52wk Range:0.38 - 0.69
    Volume:320,356
    Avg Vol (3m):713,195
    Market Cap:77.27M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MSTX

    Comparison

    Symbol% ChgMkt Cap
    MSTXDown 2.62%77.27M
    GSKDown 3.15%95.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.24
    Quarterly EPS Est (Sep-15) :-0.06
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cel... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback